Next Article in Journal
Stability-Indicating High-Performance Liquid Chromatographic Determination of Apixaban in the Presence of Degradation Products
Previous Article in Journal
Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 82
Issue 4
10.3797/scipharm.1403-12
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application

by
Shivanand DHANURE
,
Atulkumar SAVALIA
,
Pravinkumar MORE
,
Prashant SHIRODE
*,
Kailas KAPSE
and
Virag SHAH
Micro Labs Limited, Banglore, Karnataka, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2014, 82(4), 765-776; https://doi.org/10.3797/scipharm.1403-12
Submission received: 10 March 2014 / Accepted: 22 May 2014 / Published: 22 May 2014
Versions Notes

Abstract

A simple, sensitive, and selective LC-MS/MS method was developed and validated for the quantification of carbocisteine in human plasma. Rosiglitazone was used as the internal standard and heparin was used as the anticoagulant. The chromatographic separation was performed by using the Waters Symmetry Shield RP 8, 150 x 3.9 mm, 5 μm column at 40°C with a mobile phase consisting of a mixture of methanol and 0.5% formic acid solution in a 40:60 proportion. The flow rate was 500 μl/min along with a 5 μl injection volume. Protein precipitation was used as the extraction method. Mass spectrometric data were detected in positive ion mode. The MRM mode of the ions for carbocisteine was 180.0 > 89.0 and for rosiglitazone it was 238.1 > 135.1. The method was validated in the concentration curve range of 50.000 ng/mL to 6000.000 ng/mL. The retention times of carbocisteine and the internal standard rosiglitazone were approximately 2.20 and 3.01 min, respectively. The overall run time was 4.50 min. This method was found suitable to analyze human plasma samples for the application in pharmacokinetic and BA/BE studies.
Keywords: Carbocisteine; Bioanalytical; Plasma; Chromatography; Rosiglitazone; LC-MS/MS Carbocisteine; Bioanalytical; Plasma; Chromatography; Rosiglitazone; LC-MS/MS

Share and Cite

MDPI and ACS Style

DHANURE, S.; SAVALIA, A.; MORE, P.; SHIRODE, P.; KAPSE, K.; SHAH, V. Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application. Sci. Pharm. 2014, 82, 765-776. https://doi.org/10.3797/scipharm.1403-12

AMA Style

DHANURE S, SAVALIA A, MORE P, SHIRODE P, KAPSE K, SHAH V. Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application. Scientia Pharmaceutica. 2014; 82(4):765-776. https://doi.org/10.3797/scipharm.1403-12

Chicago/Turabian Style

DHANURE, Shivanand, Atulkumar SAVALIA, Pravinkumar MORE, Prashant SHIRODE, Kailas KAPSE, and Virag SHAH. 2014. "Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application" Scientia Pharmaceutica 82, no. 4: 765-776. https://doi.org/10.3797/scipharm.1403-12

APA Style

DHANURE, S., SAVALIA, A., MORE, P., SHIRODE, P., KAPSE, K., & SHAH, V. (2014). Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application. Scientia Pharmaceutica, 82(4), 765-776. https://doi.org/10.3797/scipharm.1403-12

Article Metrics

Back to TopTop